Analysts Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $596.05

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned a consensus recommendation of “Moderate Buy” from the nineteen ratings firms that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $596.05.

Several research analysts recently weighed in on the company. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Truist Financial dropped their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Finally, Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,286 shares of company stock worth $12,594,546. 0.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently modified their holdings of the stock. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Hurley Capital LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. Chilton Capital Management LLC raised its holdings in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares in the last quarter. Finally, BankPlus Trust Department acquired a new stake in Intuitive Surgical during the 4th quarter valued at $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.3%

Shares of Intuitive Surgical stock opened at $551.85 on Friday. The stock’s fifty day moving average is $518.20 and its 200-day moving average is $538.82. The firm has a market capitalization of $197.79 billion, a PE ratio of 86.09, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical has a 12-month low of $397.47 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the firm earned $1.50 earnings per share. Analysts expect that Intuitive Surgical will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.